RedHill Biopharma (RDHL) Gains from Investment Securities (2019 - 2022)
RedHill Biopharma (RDHL) reported Gains from Investment Securities of $823000.0 for Q4 2022, up 1103.66% year-over-year from $68374.9 in Q4 2021, and down 82.74% quarter-over-quarter from $4.8 million in Q1 2022.
RedHill Biopharma (RDHL) Gains from Investment Securities (2019 - 2022) Analysis & Trends
RedHill Biopharma (RDHL) has 4 years of Gains from Investment Securities data on file, last reported at $823000.0 in Q4 2022.
- Gains from Investment Securities for Q4 2022 came in at $823000.0, up 1103.66% year-over-year; the trailing twelve-month figure through Dec 2022 was $5.6 million (up 443.77% YoY), and the FY2025 annual result was $1.0 million, changed N/A from the prior year.
- Gains from Investment Securities fell to $823000.0 in Q4 2022 per RDHL's latest filing, from $4.8 million in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $4.8 million in Q1 2022 and troughed at -$82000.0 in Q4 2021.
- A 4-year average of $1.1 million and a median of $630000.0 in 2020 frame the typical range for Gains from Investment Securities.
- The sharpest annual moves came in 2021 and 2022: Gains from Investment Securities plunged 142.71% in 2021, then surged 1103.66% in 2022.
- A 4-year view of Gains from Investment Securities shows it stood at $124000.0 in 2019, then surged by 54.84% to $192000.0 in 2020, then plunged by 142.71% to -$82000.0 in 2021, then surged by 1103.66% to $823000.0 in 2022.
- Business Quant data shows RDHL's Gains from Investment Securities at $823000.0 in Q4 2022, $4.8 million in Q1 2022, and -$82000.0 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn |
| 10 | RedHill Biopharma | 129.54 Mn | 129.54 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 823,000.00 |
| Dec 31, 2022 | 823,000.00 |
| Mar 31, 2022 | 4.77 Mn |
| Mar 31, 2022 | 4.77 Mn |
| Dec 31, 2021 | -82,000.00 |
| Dec 31, 2021 | -82,000.00 |
| Sep 30, 2021 | 385,000.00 |
| Sep 30, 2021 | 385,000.00 |
| Dec 31, 2020 | 192,000.00 |
| Dec 31, 2020 | 192,000.00 |
| Sep 30, 2020 | 533,000.00 |
| Sep 30, 2020 | 533,000.00 |
| Jun 30, 2020 | 630,000.00 |
| Jun 30, 2020 | 630,000.00 |
| Mar 31, 2020 | 1.58 Mn |
| Mar 31, 2020 | 1.58 Mn |
| Dec 31, 2019 | 124,000.00 |
| Dec 31, 2019 | 124,000.00 |
| Jun 30, 2019 | 1.10 Mn |
| Jun 30, 2019 | 1.10 Mn |